GR3029628T3 - A novel biologically active peptide derived from chicken (chicken CNP) - Google Patents

A novel biologically active peptide derived from chicken (chicken CNP)

Info

Publication number
GR3029628T3
GR3029628T3 GR990400718T GR990400718T GR3029628T3 GR 3029628 T3 GR3029628 T3 GR 3029628T3 GR 990400718 T GR990400718 T GR 990400718T GR 990400718 T GR990400718 T GR 990400718T GR 3029628 T3 GR3029628 T3 GR 3029628T3
Authority
GR
Greece
Prior art keywords
chicken
biologically active
cnp
active peptide
peptide derived
Prior art date
Application number
GR990400718T
Other languages
English (en)
Inventor
Hisayuki Matsuo
Kenji Kangawa
Naoto Minamino
Original Assignee
Suntory Ltd
Hisayuki Matsuo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd, Hisayuki Matsuo filed Critical Suntory Ltd
Publication of GR3029628T3 publication Critical patent/GR3029628T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GR990400718T 1990-09-07 1999-03-09 A novel biologically active peptide derived from chicken (chicken CNP) GR3029628T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2238293A JP2977158B2 (ja) 1990-09-07 1990-09-07 トリ由来新規生理活性ペプチド（ニワトリｃｎｐ）

Publications (1)

Publication Number Publication Date
GR3029628T3 true GR3029628T3 (en) 1999-06-30

Family

ID=17028039

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990400718T GR3029628T3 (en) 1990-09-07 1999-03-09 A novel biologically active peptide derived from chicken (chicken CNP)

Country Status (8)

Country Link
US (1) US5338830A (el)
EP (1) EP0475291B1 (el)
JP (1) JP2977158B2 (el)
AT (1) ATE175210T1 (el)
DE (1) DE69130696T2 (el)
DK (1) DK0475291T3 (el)
ES (1) ES2127190T3 (el)
GR (1) GR3029628T3 (el)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0203172B8 (pt) 2001-09-28 2021-05-25 Nakao Kazuwa composição farmacêutica para acondroplasia
CN1960758B (zh) 2004-03-31 2014-10-22 中外制药株式会社 关节炎的治疗剂或预防剂
EP1743653A4 (en) 2004-03-31 2009-09-30 Kazuwa Nakao COMPOSITION FOR INCREASING BODY SIZE
EP1759001B1 (en) 2004-04-21 2011-04-13 Enobia Pharma Inc. Bone delivery conjugates and method of using same to target proteins to bone
CA2823066A1 (en) 2010-12-27 2012-07-05 Alexion Pharma International Sarl Compositions comprising natriuretic peptides and methods of use thereof
US10052366B2 (en) 2012-05-21 2018-08-21 Alexion Pharmaceuticsl, Inc. Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
US10822596B2 (en) 2014-07-11 2020-11-03 Alexion Pharmaceuticals, Inc. Compositions and methods for treating craniosynostosis
MX2017007392A (es) 2014-12-05 2019-01-24 Alexion Pharma Inc Tratamiento de convulsiones con fosfatasa alcalina recombinante.
JP6868561B2 (ja) 2015-01-28 2021-05-12 アレクシオン ファーマシューティカルズ， インコーポレイテッド アルカリホスファターゼ欠損を有する被験者を治療する方法
WO2017022728A1 (ja) * 2015-07-31 2017-02-09 株式会社イギス Ｃｎｐ環状ペプチド並びに該環状ペプチドを含む医薬品、外用剤および化粧料
AU2016308624B2 (en) 2015-08-17 2022-06-23 Alexion Pharmaceuticals, Inc. Manufacturing of alkaline phosphatases
JP6868617B2 (ja) 2015-09-28 2021-05-12 アレクシオン ファーマシューティカルズ， インコーポレイテッド 低ホスファターゼ血症の組織非特異的アルカリホスファターゼ（ｔｎｓａｌｐ）酵素補充療法に有効な投薬計画の特定
EP3368062A4 (en) 2015-10-30 2019-07-03 Alexion Pharmaceuticals, Inc. METHODS OF TREATING CRANIOSYNOSTOSIS IN A PATIENT
US11065306B2 (en) 2016-03-08 2021-07-20 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in children
EP3436020A4 (en) 2016-04-01 2019-12-25 Alexion Pharmaceuticals, Inc. METHOD FOR TREATING HYPOPHOSPHATASIE IN TEENS AND ADULTS
EP3436052A4 (en) 2016-04-01 2019-10-09 Alexion Pharmaceuticals, Inc. TREATMENT OF MUSCLE WEAKNESS USING ALKALINE PHOSPHATASES
US10988744B2 (en) 2016-06-06 2021-04-27 Alexion Pharmaceuticals, Inc. Method of producing alkaline phosphatase
US11116821B2 (en) 2016-08-18 2021-09-14 Alexion Pharmaceuticals, Inc. Methods for treating tracheobronchomalacia
EP3600383A4 (en) 2017-03-31 2020-10-28 Alexion Pharmaceuticals, Inc. METHODS FOR TREATMENT OF HYPOPHOSPHATASIA (HPP) IN ADULTS AND ADOLESCENTS
EP3773684A1 (en) 2018-03-30 2021-02-17 Alexion Pharmaceuticals, Inc. Manufacturing of glycoproteins
EP4291224A1 (en) 2021-02-12 2023-12-20 Alexion Pharmaceuticals, Inc. Alkaline phosphatase polypeptides and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2544929B2 (ja) * 1987-06-17 1996-10-16 第一化学薬品 株式会社 新規生理活性ペプチド
US5114923A (en) * 1988-05-31 1992-05-19 California Biotechnology Inc. Recombinant techniques for production of novel natriuretic and vasodilator peptides

Also Published As

Publication number Publication date
DK0475291T3 (da) 1999-08-30
DE69130696D1 (de) 1999-02-11
JP2977158B2 (ja) 1999-11-10
EP0475291B1 (en) 1998-12-30
DE69130696T2 (de) 1999-06-10
JPH04120094A (ja) 1992-04-21
EP0475291A1 (en) 1992-03-18
ATE175210T1 (de) 1999-01-15
ES2127190T3 (es) 1999-04-16
US5338830A (en) 1994-08-16

Similar Documents

Publication Publication Date Title
GR3029628T3 (en) A novel biologically active peptide derived from chicken (chicken CNP)
GR3029632T3 (en) A novel biologically active peptide derived from frog (frog CNP)
HUT43582A (en) Process for production of derivatives of 4,5,6-substituated-n-/substituated phenil/-piramidin-amin and medical compounds containing thereof
PT1538202E (pt) Produção de alga-galactosidase a humana
DE69307800D1 (de) Reaktionssystem zur Herstellung von mikrozellularen Elastomeren
EP0247906A3 (en) Dna coding for anti-tumour polypeptides, the polypeptides and anti-tumour agents comprising said polypeptides
NO895028D0 (no) Ny chimerisk transformerende vekstfaktor-beta.
GR3020440T3 (en) Enantioselective synthesis of antifolates
EP0317627A4 (en) Oncogene-encoded polypeptide having growth factor activity and methods of production and use thereof
AU7080491A (en) Substituted triazolopyridazines
ATE133709T1 (de) Peroxidase-gen von mikrobischem ursprung
FR2520740B1 (el)
ATE47880T1 (de) Vorlaeufer eines an dem c-ende amidierten peptids und dessen herstellung.
NZ238331A (en) Peptide with peptidylhydroxyglycine n-c lyase activity, dna encoding it and its preparation and its use
PT82322A (en) Process for preparing cycloalkanecarboxanilides
DE3565525D1 (en) Process for the preparation of monochloroacetic acid from glycolic acid
UA29465C2 (uk) Спосіб одержання карбаміду
DE59407667D1 (de) Verfahren zur Herstellung von Azaphenothiazinen
IL83118A (en) N-acylated-n)- alkylcarbothioic acid hydrazides
SE8403252D0 (sv) Forfarande vid forbrenning, jemte brensle
UA23007A1 (uk) 9-метокси-10-етил-12h-хромено[3',2'-3,4]піроло[1,2-а]-хінолін-12-oh, що володіє аналептичною дією та спосіб його отримання
LTIP1501A (en) Using of known combination for treatment of rejection reaction by transplantation of organs